Evaluation of the applicability of the aquatic ascomycete sp. UHH 5-1-03 for the removal of pharmaceutically active compounds from municipal wastewaters using membrane bioreactors.

Membrane bioreactors (MBRs) augmented with terrestrial white-rot basidiomycetes have already been tested for the removal of pharmaceutically active compounds (PhACs) from wastewaters. Within the present study, an aquatic ascomycete ( sp.) was initially demonstrated to efficiently remove several PhACs at their real environmental trace concentrations from nonsterile municipal wastewater on a laboratory scale.

Isolation of bacterial strains capable of sulfamethoxazole mineralization from an acclimated membrane bioreactor.

In this study, we isolated five strains capable of degrading ¹⁴C-labeled sulfamethoxazole to ¹⁴CO₂ from a membrane bioreactor acclimatized to sulfamethoxazole, carbamazepine, and diclofenac. Of these strains, two belonged to the phylum Actinobacteria, while three were members of the Proteobacteria.